Stifel Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsOct 31 09:31 ET · Ratings

Contineum Draws Bullish View at Baird on De-risked Assets

Seeking AlphaOct 22 11:56 ET

Baird Initiates Contineum Therapeutics(CTNM.US) With Buy Rating, Announces Target Price $32

Moomoo NewsOct 21 16:32 ET · Ratings

Promising Prospects and Strong Financials Bolster Buy Rating for Contineum Therapeutics

TipRanksOct 21 16:25 ET

We're Interested To See How Contineum Therapeutics (NASDAQ:CTNM) Uses Its Cash Hoard To Grow

Simply Wall StOct 7 11:36 ET

Contineum Therapeutics, Inc.'s (NASDAQ:CTNM) Largest Shareholders Are Individual Investors With 41% Ownership, Institutions Own 28%

Yahoo FinanceOct 4 07:40 ET